WANY
EXAS

Wealthspire Advisors (New York)’s Exact Sciences EXAS Stock Holding History

Wealthspire Advisors (New York)’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-121
Closed -$6.62K – 1621
2025
Q3 		$6.62K Buy
+121
New +$6.05K ﹤0.01% 2212
2023
Q3 		– Sell
-5,565
Closed -$523K – 604
2023
Q2 		$523K Buy
5,565
+36
+0.7% +$2.81K 0.01% 352
2023
Q1 		$375K Sell
5,529
-444
-7% -$28.5K 0.01% 400
2022
Q4 		$296K Buy
+5,973
New +$244K 0.01% 458
2022
Q3 		– Sell
-6,026
Closed -$237K – 524
2022
Q2 		$237K Hold
6,026
– – 0.01% 448
2022
Q1 		$421K Sell
6,026
-353
-6% -$25.8K 0.01% 295
2021
Q4 		$496K Sell
6,379
-938
-13% -$82.8K 0.01% 323
2021
Q3 		$698K Buy
7,317
+99
+1% +$10.5K 0.01% 299
2021
Q2 		$897K Buy
7,218
+2,685
+59% +$320K 0.02% 174
2021
Q1 		$597K Buy
4,533
+515
+13% +$70.5K 0.01% 351
2020
Q4 		$532K Buy
+4,018
New +$486K 0.02% 292
2020
Q2 		– Sell
-4,715
Closed -$273K – 355
2020
Q1 		$273K Buy
+4,715
New +$383K 0.01% 406

Other funds holding EXAS

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $9.85B AUM 55.6% 1-Year Est. Return
PCM
Pentwater Capital Management Naples, Florida $19.3B AUM 58.13% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
DKCM
Davidson Kempner Capital Management New York $7.33B AUM 56.47% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Balyasny Asset Management
Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM

Wealthspire Advisors (New York)'s EXAS Position: Q4 2025 in Review

Wealthspire Advisors (New York) sold out of Exact Sciences (EXAS) in Q4 2025, closing a stake of 121 shares — an estimated $6.62K sold.

Wealthspire Advisors (New York) first reported a position in EXAS in Q1 2020 and held it in 12 quarters. The position peaked at $897K in Q2 2021. 711 funds tracked by Wall St. Rank hold EXAS as of Q4 2025.

  • Wealthspire Advisors (New York) reported no remaining Exact Sciences position as of Q4 2025 after selling out during the quarter.
  • Wealthspire Advisors (New York) sold 121 Exact Sciences shares in Q4 2025, an estimated $6.62K.
  • Wealthspire Advisors (New York) first reported a position in Exact Sciences in Q1 2020 and held it in 12 quarters.
  • Wealthspire Advisors (New York)'s Exact Sciences position peaked at $897K in Q2 2021.
  • 711 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2025.

Based on Wealthspire Advisors (New York)'s 13F filing for Q4 2025, filed 13 Feb 2026.